RARE - CIK 0001515673
Ultragenyx Pharmaceutical Inc. has filed 1,100 documents with the SEC between 2011 and 2026. The most frequent type is insider trade (563 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2024-06-17 | 2024-06-13 |
| Prospectus supplement | 424B5 | 2024-06-14 | - |
| Insider sale notice | 144 | 2024-06-12 | - |
| Prospectus supplement | 424B5 | 2024-06-12 | - |
| Insider trade | 4 | 2024-06-12 | 2024-06-12 |
| Major company event | 8-K | 2024-06-12 | 2024-06-12 |
| Major company event | 8-K | 2024-06-12 | 2024-06-11 |
| Insider sale notice | 144 | 2024-06-10 | - |
| Insider trade | 4 | 2024-06-10 | 2024-06-10 |
| SEC correspondence | UPLOAD | 2024-06-10 | - |
| Major company event | 8-K | 2024-05-30 | 2024-05-30 |
| Company correspondence | CORRESP | 2024-05-17 | - |
| Insider trade | 4 | 2024-05-03 | 2024-05-02 |
| Quarterly report | 10-Q | 2024-05-03 | 2024-03-31 |
| Major company event | 8-K | 2024-05-02 | 2024-05-02 |
| Annual report to shareholders | ARS | 2024-04-26 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-26 | - |
| Proxy statement | DEF 14A | 2024-04-26 | 2024-06-18 |
| SEC correspondence | UPLOAD | 2024-04-22 | - |
| Insider trade | 4 | 2024-04-19 | 2024-04-18 |
| Insider trade | 4 | 2024-04-18 | 2024-04-16 |
| Major company event | 8-K | 2024-04-15 | 2024-04-15 |
| Insider trade | 4 | 2024-03-12 | 2024-03-11 |
| Insider sale notice | 144 | 2024-03-11 | - |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider sale notice | 144 | 2024-03-07 | - |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| S-3ASR | - | 2024-02-21 | - |
| Annual report | 10-K | 2024-02-21 | 2023-12-31 |
| Major company event | 8-K | 2024-02-15 | 2024-02-15 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Passive ownership stake | SC 13G | 2024-02-13 | - |
| Insider trade | 4 | 2024-02-08 | 2024-02-07 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-08 | - |
| Insider sale notice | 144 | 2024-02-07 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-29 | - |
| Major company event | 8-K | 2024-01-08 | 2024-01-07 |
| Insider trade | 4 | 2024-01-02 | 2023-12-29 |
| Insider trade | 4 | 2024-01-02 | 2023-12-20 |
| Insider sale notice | 144 | 2023-12-29 | - |